Chief, Hospital Medicine Division of Supportive and Acute Care Services

Memorial Sloan Kettering Cancer Center (MSK) is one of the world’s premier cancer centers, committed to exceptional patient care, cutting-edge research, and superb educational programs. The blending of research with patient care is at the heart of everything we do. The institution is a comprehensive cancer center whose purposes are the treatment and control of cancer, the advancement of biomedical knowledge through laboratory and clinical research, and the training of scientists, physicians and other health care workers.

The Division of Supportive and Acute Care Services in the Department of Medicine at Memorial Sloan Kettering Cancer Center seeks to recruit an exceptional academic physician and leader to serve as the Chief of the Hospital Medicine Service. The Division of Supportive and Acute Care Services is comprised of five services, including Hospital Medicine, Emergency Care, Integrative Medicine and Wellness, Rapid Diagnosis, Early Detection and Risk Reduction (RaDaR), and Supportive Care that provide whole person, goal-concordant care across the cancer care continuum.

Hospital Medicine is comprised of an outstanding team of 47 faculty, a combination of daytime hospitalists and nocturnists, who have pioneered the field of “oncology hospital medicine” over the last 15 years. They specialize in delivering comprehensive inpatient medical care 24/7 to adults living with cancer, while also providing pre-operative risk assessment for surgical services and caring for MSK patients who have transitioned to our partner sub-acute care and rehabilitation center, Mary Manning Walsh.

The service provides care that is, above all else, compassionate and patient-centered, in addition to being safe and evidence-based.

The hospitalists are internal medicine trained and board-certified, and five faculty have additional board certification in hospice and palliative medicine. The 21 daytime hospitalists lead inpatient solid tumor teams staffed by either advanced practice providers or interns and residents, and have primary responsibility for the care of hospitalized patients. Persons are often admitted with complications of cancer-directed therapies or other treatments, exacerbations of comorbid conditions, and/or severe and burdensome symptoms.

The teams include a mix of persons living with breast, head and neck, gastrointestinal, genitourinary, gynecologic, melanoma, sarcoma and thoracic malignancies. The 26 nocturnists, led by their own Deputy Service Chief, admit and care for both solid tumor and hematologic malignancy patients overnight.

Faculty are expert in communication skills for persons living with serious illness, management of infectious diseases, treatment of pain and other burdensome symptoms, and the identification and treatment of complications of novel cancer therapeutics, including immunotherapy, CAR-T cell therapy, antibody drug conjugates, and other targeted therapies. They have experience managing rare but increasingly prevalent syndromes, including Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome, and Triple-M, a rare but life‑threatening side effect of immune checkpoint inhibitor therapy.

The Hospital Medicine Service is home to the top-ranked transitional year residency, the rotating internal medicine residency representing three other NYC-based academic medical centers, and the internal medicine chief residency program. The Residency Program Director and Associate Program Director of the 24-person transitional year program are both hospitalists, along with the Director of the rotating internal medicine and chief residency programs.

The Director of Medical Student Education for the Department of Medicine is also a…